Drug discovery (lecture 9 +10) Flashcards

1
Q

Describe the drug discovery process steps

A
  1. Identify disease
  2. Target identification validation
  3. Identify lead molecules
  4. optimise lead molecules
  5. preclinical trials
  6. clinical trials
  7. approval and circulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why is it difficult to design a drug?

A

because a good drug molecule needs to be able to have good efficacy at a minimal dose AND be safely administered.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do we do target validation?

A
  • using cell based assay

- Human mutations are introduced into mice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is serendipity?

A

the discovery by accident

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe some drugs that were discovered by chance?

A
  • Penicillin (antibiotic)
  • Meprobamate (Tranquilliser)
  • Chlorpromazine (anaesthetic)
  • Imipramine (depression)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the process of screening in the identification of lead molecules ?????

A

High throughput screening
natural products
designed libraries
Screening small fragments (low MW compounds)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe processes that are used in the rational drug design process

A

XRAY crystallography and molecular modelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe some parameters that determine the properties of a drug

A
  • MW
  • Number of H bond acceptors/donors
  • lipophilicity (LogP, LogD)
  • Acidity/ basicity (pKa)
  • Solubility
  • Polar surface area (PSA)

** These properties can be calculated before compounds are prepared.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the properties of a potential candidate drug

A

A molecule that has the best balance of:

  • Potency at & selectivity for target
  • Appropriate stability & distribution in the body
  • Efficacy in models of disease
  • Lack of toxicity or other effects
  • Potential for development into a medicine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What must an oral drug be able to do?

A
  • Dissolve
  • Survive a range of pHs
  • Cross membranes
  • Optimal delivery to site of target organ
  • Avoid going into undesired places
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is 1st pass metabolism?

A

Being able to pass through the liver - an oral drug must be able to do this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is 2nd pass metabolism?

A

Renal and biliary excretion - an oral drug must be able to AVOID this.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe preclinical trials

A
  • Testing the safety and efficacy of the candidate drug
  • Does the drug work in animal models?
  • Is it safe in high doses in rats and a second species such as a dog?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the different phases in a clinical trial

A
  • Phase I – Healthy normal volunteers:

Is the drug safe and well-tolerated?

  • Phase II – Patient population:

Does the drug work and if so, what is the best dose?

Phase III – Large patient population:

Does the drug work and is it better than current standard of care?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Side notes

A

Slide 21 on lecture (don’t know what we need to know from it)

  • sometimes, clinical trial phases fail and it can result in death. (don’t know if we need to know the specific examples he gave, email and ask? Slides 25-29)
  • table on slide 41
  • Flow chart on slide 42
  • slide 46
  • I stopped making notes from slide 41 onwards whoops lo;
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain a phase 1 clinical trial

A
  • Determine the metabolism and pharmacological action of drugs in humans
  • Look at how increasing dose causes side effects
  • Show some sort of evidence that it is effective

(can be patients or healthy volunteers, depends what the drug is for ygm)

17
Q

Explain a phase 2 clinical trial

A
  • Evaluation of the effectiveness of a drug for a disease

- Determine the common short term side effects and risks

18
Q

Explain a phase 3 clinical trial

A
  • Intended to gather more info so we can evaluate the overall benefits vs risks of a drug.
  • Really big cohort group usually.
19
Q

Describe some factors that might cause the failure of clinical trials?

A
  • Pharmacokinetics
  • Clinical safety
  • Commercial stuff
  • Non-clinical toxicology
  • Efficacy
  • Technical stuff
20
Q

Describe patenting in drug discovery?

A
  • Protecting the invention of a new drug
  • when the patent is filled, 18 months later it will be actually publishes so other competitors who filed in the patent earlier than you can swoop in and steal your drug
  • When patent is granted, you have the right to develop/market the drug for 20 years
21
Q

What is the average cost to develop a drug nowadays?

A

About $2.6B

22
Q

What are CNS penetrant drugs?

A

Drugs that can go through the blood brain barrier

23
Q

Name the first in class AMPA receptor antagonist and what type of antagonist is it?

What did this drug show in phase 2 clinical trials?

A

Perampanel, non competitive antagonist approved in 2012.

It showed significant reductions in seizures frequency in epilepsy, with acceptable side effects

24
Q

Describe 2 other non competitive antagonists that can displace perampanel?

A
  • GYKI52466

- CP465022